Douglas G. Johnson - Grayslake IL Allan E. Titus - Round Lake IL
Assignee:
Baxter International Inc. - Deerfield IL
International Classification:
A61K 3134 A61L 200
US Classification:
514471
Abstract:
A pharmaceutical composition is provided comprising an unbuffered iso-osmotic aqueous formulation containing an effective amount of ranitidine for the treatment of conditions mediated through histamine H. sub. 2 receptors. The formulation has a pH of greater than or equal to 5. 0 and less than 6. 5 and preferably includes an osmotic adjusting agent chosen from the group consisting of dextrose and sodium chloride.
Douglas G. Johnson - Grayslake IL Allan E. Titus - Round Lake IL
Assignee:
Baxter International Inc. - Deerfield IL
International Classification:
A61K 3134
US Classification:
514471
Abstract:
A pharmaceutical composition is provided comprising an unbuffered iso-osmotic aqueous formulation containing an effective amount of ranitidine for the treatment of conditions mediated through histamine H. sub. 2 receptors. The formulation has a pH of greater than or equal to 5. 0 and less than 6. 5 and preferably includes an osmotic adjusting agent chosen from the group consisting of dextrose and sodium chloride.
Allan E. Titus - Round Lake IL Douglas G. Johnson - Grayslake IL
Assignee:
Baxter International Inc. - Deerfield IL
International Classification:
A61K 31425
US Classification:
514370
Abstract:
A pharmaceutical composition comprising a solution having an effective amount of famotidine, the solution having a pH in the range of about 4. 5 to about 8. 0, and a shelf life greater than 30 days.
Baxter International Inc. Oct 2013 - Jul 2019
Research Scientist at Baxter Healthcare
Education:
University of Illinois at Urbana - Champaign 1984 - 1986
Bachelors, Bachelor of Science, Chemistry
University of Illinois at Urbana - Champaign 1979 - 1983
Skills:
Fda Validation Glp Analytical Chemistry Hplc Chromatography Formulation